W. J. Culpepper

Long-Term Results of Use of the Anatomic Medullary Locking Prosthesis in Total Hip Arthroplasty*

C. Engh, W. J. Culpepper, 1997, The Journal of bone and joint surgery. American volume.

Osteonecrosis of the Femoral Head Treated with Cementless Total Hip Arthroplasty*

C. Engh, J. McAuley, C. Engh, 1999, The Journal of bone and joint surgery. American volume.

Total Hip Arthroplasty: Concerns With Extensively Porous Coated Femoral Components

C. Engh, J. McAuley, W. J. Culpepper, 1998, Clinical orthopaedics and related research.

Perioperative adjuvant biotherapy in high-risk resected cutaneous melanoma: the results of 5 years of follow-up

E. Elias, W. J. Culpepper, J. Zapas, 2007, Melanoma research.

Long-Term Clinical Consequences of Stress-Shielding after Total Hip Arthroplasty without Cement*

C. Engh, W. Bugbee, C. Engh, 1997, The Journal of bone and joint surgery. American volume.

Total Hip Arthroplasty with Porous-Coated Prostheses Fixed without Cement in Patients Who Are Sixty-five Years of Age or Older*

C. Engh, J. McAuley, W. J. Culpepper, 1998, The Journal of bone and joint surgery. American volume.

Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis

M. Zhan, S. El-Kamary, H. Alexander, 2014, Medical Oncology.

Revision of Loose Cementless Femoral Prostheses to Larger Porous Coated Components

C. Engh, W. J. Culpepper, Elias Kassapidis, 1998, Clinical orthopaedics and related research.

Sequential administration of GM-CSF (Sargramostim) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial.

E. Elias, W. J. Culpepper, J. Hasskamp, 2008, Cancer biotherapy & radiopharmaceuticals.